International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Kumar, Shaji, Prof, Paiva, Bruno, PhD, Anderson, Kenneth C, Prof, Durie, Brian, Prof, Landgren, Ola, MD, Moreau, Philippe, Prof, Munshi, Nikhil, Prof, Lonial, Sagar, MD, Bladé, Joan, Prof, Mateos, Maria-Victoria, Prof, Dimopoulos, Meletios, Prof MD, Kastritis, Efstathios, MD, Boccadoro, Mario, Prof, Orlowski, Robert, Prof, Goldschmidt, Hartmut, Prof, Spencer, Andrew, Prof, Hou, Jian, Prof, Chng, Wee Joo, Prof, Usmani, Saad Z, MD, Zamagni, Elena, MD, Shimizu, Kazuyuki, Prof, Jagannath, Sundar, Prof, Johnsen, Hans E, Prof, Terpos, Evangelos, MD, Reiman, Anthony, Prof, Kyle, Robert A, Prof, Sonneveld, Pieter, Prof, Richardson, Paul G, Prof, McCarthy, Philip, Prof, Ludwig, Heinz, Prof, Chen, Wenming, Prof, Cavo, Michele, Prof, Harousseau, Jean-Luc, Prof, Lentzsch, Suzanne, Prof, Hillengass, Jens, MD, Palumbo, Antonio, Prof, Orfao, Alberto, Prof, Rajkumar, S Vincent, Prof, Miguel, Jesus San, Prof, Avet-Loiseau, Herve, Prof
Published in The lancet oncology (01.08.2016)
Published in The lancet oncology (01.08.2016)
Get full text
Journal Article
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
Durie, Brian G M, Dr Prof, Hoering, Antje, PhD, Abidi, Muneer H, MD, Rajkumar, S Vincent, Prof, Epstein, Joshua, Prof, Kahanic, Stephen P, MD, Thakuri, Mohan, MD, Reu, Frederic, MD, Reynolds, Christopher M, MD, Sexton, Rachael, MS, Orlowski, Robert Z, Prof, Barlogie, Bart, Prof, Dispenzieri, Angela, Prof
Published in The Lancet (British edition) (04.02.2017)
Published in The Lancet (British edition) (04.02.2017)
Get full text
Journal Article
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
Fowler, Nathan H, Dr, Davis, R Eric, MD, Rawal, Seema, PhD, Nastoupil, Loretta, MD, Hagemeister, Fredrick B, Prof, McLaughlin, Peter, Prof, Kwak, Larry W, Prof, Romaguera, Jorge E, Prof, Fanale, Michelle A, MD, Fayad, Luis E, MD, Westin, Jason R, MD, Shah, Jatin, MD, Orlowski, Robert Z, Prof, Wang, Michael, Prof, Turturro, Francesco, Prof, Oki, Yasuhiro, MD, Claret, Linda C, RN, Feng, Lei, MS, Baladandayuthapani, Veerabhadran, PhD, Muzzafar, Tariq, MD, Tsai, Kenneth Y, MD, Samaniego, Felipe, MD, Neelapu, Sattva S, MD
Published in The lancet oncology (01.11.2014)
Published in The lancet oncology (01.11.2014)
Get full text
Journal Article
Role of18 F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
Cavo, Michele, Prof, Terpos, Evangelos, Prof, Nanni, Cristina, MD, Moreau, Philippe, Prof, Lentzsch, Suzanne, MD, Zweegman, Sonja, Prof, Hillengass, Jens, Prof, Engelhardt, Monika, Prof, Usmani, Saad Z, Prof, Vesole, David H, Prof, San-Miguel, Jesus, Prof, Kumar, Shaji K, Prof, Richardson, Paul G, Prof, Mikhael, Joseph R, MD, da Costa, Fernando Leal, MD, Dimopoulos, Meletios-Athanassios, Prof, Zingaretti, Chiara, PhD, Abildgaard, Niels, Prof, Goldschmidt, Hartmut, Prof, Orlowski, Robert Z, Prof, Chng, Wee Joo, Prof, Einsele, Hermann, Prof, Lonial, Sagar, Prof, Barlogie, Bart, Prof, Anderson, Kenneth C, Prof, Rajkumar, S Vincent, Prof, Durie, Brian G M, MD, Zamagni, Elena, MD
Published in The lancet oncology (2017)
Published in The lancet oncology (2017)
Get full text
Journal Article
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar
Published in The Lancet. Haematology (01.06.2017)
Published in The Lancet. Haematology (01.06.2017)
Get more information
Journal Article